Table 2. Distribution of comorbid diseases/cardiovascular risk factors among peripheral-vestibular vertigo and non-vestibular vertigo group.
| Comorbid diseases/cardiovascularrisk factors | Peripheral-vestibularvertigo (n = 19) | Non-vestibular vertigo (n = 69) | Total (n = 88) | P value |
| Hypertension* | 5 (18%) | 23 (82%) | 28 (32%) | >0.05 |
| Pre-hypertension* | 8 (24%) | 25 (76%) | 33 (38%) | >0.05 |
| Diabetes mellitus* | 3 (25%) | 9 (75%) | 12 (14%) | >0.05 |
| Ischemic heart disease* | 2 (20%) | 8 (80%) | 10 (11%) | >0.05 |
| Cerebrovascular stroke* | 0 (0%) | 5 (100%) | 5 (6%) | >0.05 |
| Current smokers* | 3 (21%) | 11 (79%) | 14 (16%) | >0.05 |
*
Expected cell count in one of the cells was less than 5 so Fisher’s exact test was used. Values are number of patients. Figures in parenthesis represent the row percentage.